Cargando…
COVID-19 – A vascular disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have a...
Autores principales: | Siddiqi, Hasan K., Libby, Peter, Ridker, Paul M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556303/ https://www.ncbi.nlm.nih.gov/pubmed/33068723 http://dx.doi.org/10.1016/j.tcm.2020.10.005 |
Ejemplares similares
-
Hyperlipidemia as an Instigator of Inflammation: Inaugurating New Approaches to Vascular Prevention
por: Ridker, Paul M.
Publicado: (2012) -
Plasma Pentraxin 3 Levels Do Not Predict Coronary Events but Reflect Metabolic Disorders in Patients with Coronary Artery Disease in the CARE Trial
por: Miyazaki, Tetsuro, et al.
Publicado: (2014) -
COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection
por: Siddiqi, Hasan K., et al.
Publicado: (2020) -
Targeting cytokine storm in COVID-19: what have we learned?
por: Ridker, Paul M
Publicado: (2021) -
Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease
por: Inciardi, Riccardo M., et al.
Publicado: (2020)